David Jannetti and family members in 2023 sued Stifel Nicolaus & Co., the broker-dealer subsidiary of Stifel Financial, claiming at least $5 million in damages related to investments in structured ...

(Reuters) - Stifel Financial was ordered by a Financial Industry Regulatory Authority arbitration panel to pay a family $132.5 million for misrepresenting the risk of complex structured notes ...

Shares in financial firm Stifel (SF) dropped 3% today after it was told to cough up $132.5 million in damages to a U.S. family who suffered from poor advice. Staggering Losses for Family Stifel ...

Stifel has been hit with a large penalty in an arbitration case stemming from a broker’s structured-notes strategy that has resulted in more than a dozen investor complaints.

A Finra arbitration panel has ordered Stifel Financial Corp. to pay about $132 million in damages for allegedly misleading investors by pitching a product as less risky than it actually was ...

Finra panel says Stifel was 'required to have heightened supervision' of a broker A Finra arbitration panel has ordered Stifel Financial Corp. to pay about $132 million in damages for allegedly ...

(Reuters) - Stifel Financial was ordered by a Financial Industry Regulatory Authority arbitration panel to pay a family $132.5 million for misrepresenting the risk of complex structured notes, causing ...

ST. LOUIS, March 10, 2025 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today appointed Jonathan Siegmann as Managing Director of Equity Research, covering the aerospace and defense industry.

Contineum Therapeutics (Nasdaq: CTNM) is a clinical-stage biopharmaceutical company pioneering novel, oral small molecule therapies for NI&I indications with significant unmet need. Contineum is ...

On Friday, Stifel analysts highlighted a selection of Med-Tech stocks that present favorable risk/reward opportunities, despite the industry’s current challenges with back-end weighted guidance ...

Stifel Financial Corporation (Symbol: SF) presently has an excellent rank, in the top 25% of the coverage universe, which suggests it is among the top most "interesting" ideas that merit further ...

Stifel Nicolaus analyst J. Parker Lane maintained a Buy rating on Guidewire (GWRE – Research Report) today and set a price target of $230.00. See what stocks are receiving Strong Buy ratings ...